Ulcerative colitis (UC) is a chronic inflammatory condition of the colon that has seen a steady global rise in both incidence and prevalence. Characterized by abdominal pain, diarrhea, and rectal bleeding, UC can lead to severe complications, including an increased risk of colon cancer. While the exact cause remains unknown, both Western and Eastern medical perspectives suggest that immune dysregulation, gut microbiota imbalance, and persistent inflammation are key contributing factors.
Modern treatments typically involve corticosteroids and anti-inflammatory drugs, which may offer symptom relief but often come with significant side effects and long-term dependency. In contrast, traditional herbal therapies—particularly those involving bioactive polysaccharides—have shown promising therapeutic potential with fewer side effects. A recent study explored the effects of Lycium barbarum polysaccharides (LBP) on UC, shedding new light on this time-honored herbal remedy.
Goji berries (Lycium barbarum L.), long celebrated in Traditional Chinese Medicine (TCM) for their liver- and kidney-nourishing properties, contain a high concentration of water-soluble polysaccharides known as LBP, the fruit’s most active component. These polysaccharides have been linked to immune regulation, antioxidant activity, and intestinal health support.
In a controlled laboratory study, researchers induced chronic UC in mice using dextran sulfate sodium (DSS), a standard experimental model. Mice were then treated with varying doses of purified LBP to evaluate its impact on intestinal inflammation, gut barrier function, and metabolic pathways.
Conventional UC treatments often fall short in long-term efficacy and safety. This study provides compelling evidence that goji berry polysaccharides may serve as a natural, multi-target therapy—not only relieving symptoms but addressing deeper immunological and microbial imbalances at the root of UC. By activating the gut’s own regulatory networks, LBP offers a holistic and scientifically grounded alternative to synthetic drugs.
